sharecast

{{ storiesRelated.title }}

ReNeuron Group (RENE)

142.50p

15:55 21/02/20

  • 4.40% 6.00p
  • Today's Low & High
  • 135.00 / 143.00
  • Open / Previous Close
  • 136.50 / 142.50
  • 52-week range
  • 152.21% 86.00p
  • Volume
  • 63,434
  • Market Cap(million)
  • £45.36m

Latest deals

slide to see more
Traded Action Notifier Price Amount Value
18-Apr-19  Buy Christopher Evans 228.70p 10,000 £22,870.00
11-Apr-19  Buy Christopher Evans 221.50p 4,500 £9,967.50
11-Apr-19  Buy Mike Owen 236.00p 4,237 £9,999.32
11-Apr-19  Buy Simon Christopher Cartmell 225.55p 7,758 £17,498.29
11-Apr-19  Buy John Edward Berriman 225.00p 80,000 £180,000.00

Largest deals (365 days)

slide to see more
Traded Action Notifier Price Amount Value
11-Apr-19  Buy John Edward Berriman 225.00p 80,000 £180,000.00
18-Apr-19  Buy Christopher Evans 228.70p 10,000 £22,870.00
11-Apr-19  Buy Simon Christopher Cartmell 225.55p 7,758 £17,498.29
11-Apr-19  Buy Mike Owen 236.00p 4,237 £9,999.32
11-Apr-19  Buy Christopher Evans 221.50p 4,500 £9,967.50

Director Shareholdings

slide to see more
Notifier Holding Value*
Christopher Evans 254,605 £362,812.11
John Edward Berriman 90,434 £128,868.45
Michael Hunt 27,546 £39,253.05
Olav Hellebø 21,630 £30,822.75
Simon Christopher Cartmell 15,633 £22,277.02
* Value is calculated by using the current share price multiplied by the amount held.

Major Shareholdings

slide to see more
Notifier** Holding Value
Woodford Investment Management LLP 5,277,900 £7,521,007.25
Schroders plc 5,277,900 £7,521,007.25
Obotritia Capital KGaA 4,975,757 £7,090,453.49
Invesco Limited 3,132,955 £4,464,460.73
The Wales Life Sciences Investment Fund LP 3,000,000 £4,274,999.86
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.